Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Compass Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 55 | +18 |
| Shares | 63.9M | 1.55M | 79.8M | +17.5M (+28.1%) |
| Value | $145.6M | $3.54M | $401.4M | +$259.3M (+182.5%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Compass Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Braidwell LP | 1,814,266 | $9.13M | 0.31% |
| Baker Bros. Advisors LP | 1,557,630 | $7.83M | 0.05% |
| Alyeska Investment Group, L.P. | 545,170 | $2.73M | 0.03% |
| Hudson Bay Capital Management LP | 311,500 | $1.49M | 0.02% |
| State Street Corp | 270,113 | $1.36M | 0.00% |
| Caxton Corp | 211,159 | $1.06M | 2.71% |
| Qube Research & Technologies Ltd | 62,995 | $316.9K | 0.00% |
| Citadel Advisors LLC | 62,276 | $313.2K | 0.00% |
| 683 Capital Management, LLC | 38,039 | $191.3K | 0.02% |
| Mirabella Financial Services LLP | 30,444 | $153.1K | 0.01% |
| Jump Financial, LLC | 29,200 | $146.9K | 0.01% |
| Balyasny Asset Management LLC | 28,793 | $144.8K | 0.00% |
| Man Group plc | 25,305 | $127.3K | 0.00% |
| Boothbay Fund Management, LLC | 17,130 | $86.2K | 0.00% |
| National Asset Management, Inc. | 14,918 | $75.0K | 0.00% |
| Lighthouse Investment Partners, LLC | 14,662 | $73.8K | 0.01% |
| Cubist Systematic Strategies, LLC | 10,300 | $51.8K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,160 | $6.00K | 0.00% |
| Bank of America Corp | 82 | $412 | 0.00% |
Sold out (1)
Institutions that held Compass Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Royal Bank of Canada | 675 | $2.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Compass Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 1,554,250 | $3.54M |